ArticleOncology reports2023

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.

Yoshitaro Shindo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.